Abstract:Abstract Background Mitral valve regurgitation (MVR) represents the second most frequent valvular heart disease. MV surgical repair is often the preferred treatment when MV anatomy is suitable. Purpose To characterize the population who underwent MV repair surgery and evaluate the outcomes of residual MVR, allcause mortality and functional classification. Methods Retrospective analysis of 262 patients (P) admitted between 2008 and 2017 for MV repair surgery. P who undergone simultaneous coronary artery bypass graft (CABG) surgery, atrial fibrillation (AF) surgery and tricuspid valve repair were also included. P with endocarditis, P who underwent simultaneous aortic valve replacement and P with rheumatic predominant MV stenosis were excluded, the remaining 204 P were analysed. Clinical and echocardiographic characteristics were evaluated in a mean follow-up of 30 months. Results 204 P, 67.2% male, mean age 62 + 14 years. The most frequent etiology was organic (80.4%), mostly of degenerative cause. Functional etiology was present in 19.6%, mostly ischemic (72.4%). 16.8% underwent simultaneous CABG, 12.3% tricuspid valve repair and 7.8% AF ablation. Hypertension was significantly associated with functional etiology (90% vs 72.8%, p = 0.022), as well as hypercholesterolemia (80% vs 48.2%, p < 0.001) and diabetes mellitus (32.5% vs 10.4%, p < 0.001). Baseline left ventricular ejection fraction (LVEF) was >50% in 78.4%, reduced (30-50%) 18.1% and poor (<30%) in 3.4%. Functional etiology was significantly associated with LVEF <50% (70% vs 9.1%, p < 0.001). 161P (78.9%) had MV prolapse: 120P (74.5%) posterior, 29P (18%) anterior and 7.4% (12P) of both leaflets. P2 was the most frequently involved scallop, in 92P (57.1%), followed by P3, in 41P (25.4%). There was MV chordae rupture in 94P (58.3%). Post-surgery echocardiography revealed that 93.8% had mild or no residual MVR. 30-day mortality rate was 0%. There was MVR recurrence with MV replacement surgery in 15P (7.5%), mean time 37.1 months. All-cause mortality was registered in 28P (13.7%), with a mean time of 43.7 months after MV surgery. Of the P without MVR recurrence or mortality, 111P (70%) were in NYHA class I, 41P (26%) in NYHA class II and 6P (4%) in NYHA class III. 6P were lost to follow-up. Upon echocardiographic revaluation there was no residual MVR in 53P (39%), mild MVR in 67P (49%) and moderate MVR in 16P (11.8%). Conclusion In P who underwent MV repair surgery, there was 7.5% recurrence rate with follow-up MV replacement surgery and an all-cause mortality of 13.7%. In a mean follow-up of 30 months, 70% of P were in NYHA I class and there was none or mild residual MVR in 88% of P.

Characterization of atrial arrhythmias following mitral valve repair: Incidence and risk factors

Clinical Factors Associated with Arrhythmia and Short-Term Prognosis Following Mitral Valve Repair: a Retrospective Cohort Study

Preoperative risk factors of medium-term mitral valve repair outcome

Noncomplex ventricular arrhythmia associated with greater freedom from recurrent ectopy at 1 year after mitral repair surgery

Characteristics, Mechanism And Long-Term Ablation Outcome Of Atrial Tachycardias After Mitral Valvular Surgery And Concomitant Cox-Maze Iv Procedure

Thromboembolic events early after mitral valve repair: incidence and predictive factors

Arrhythmogenesis of surgical atrial incisions and lesions in Maze procedure: insights from high-resolution mapping of atrial tachycardias.

Left atrial function and not volume predicts mid-to-late atrial fibrillation after mitral valve repair

Long-term Outcomes of Mitral Valve Repair for Atrial Functional Mitral Regurgitation

Procedural factors associated with early postoperative arrhythmias after repair of congenital heart defects

Mitral Valve Repair and Surgical Ablation for Atrial Functional Mitral Regurgitation

Surgical outcome of mitral valve surgery in atrial functional mitral regurgitation compared with degenerative etiology

Prevalence, characteristics, and long-term outcomes of patients with mitral annular disjunction undergoing surgery for degenerative mitral regurgitation

Durability of annuloplasty in patients with atrial functional mitral regurgitation associated with atrial fibrillation

[Arrhythmia in the Long-Term Follow-Up after Intracardiac Repair of Tetralogy of Fallot].

Mitral valve repair and concomitant maze procedure versus catheter ablation in the treatment of atrial functional mitral regurgitation

Surgical ablation of atrial fibrillation during mitral valve surgery: a systematic review and meta-analysis

Adjuncts to annuloplasty in atrial functional mitral regurgitation

Early and long-term outcomes of mitral valve repair in degenerative mitral regurgitation

Histopathological characteristics and oxidative injury secondary to atrial fibrillation in the left atrial appendages of patients with different forms of mitral valve disease.

P1755 Clinical and echocardiographic outcomes of mitral valve repair surgery